Cargando…

Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up

Detalles Bibliográficos
Autores principales:	Wiemer, Marcus, Stojkovic, Sinisa, Samol, Alexander, Dimitriadis, Zisis, Ruiz-Nodar, Juan M., Birkemeyer, Ralf, Monsegu, Jacques, Finet, Gérard, Hildick-Smith, David, Tresukosol, Damras, Novo, Enrique Garcia, Koolen, Jacques J., Barbato, Emanuele, Danzi, Gian Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418688/ https://www.ncbi.nlm.nih.gov/pubmed/28472961 http://dx.doi.org/10.1186/s12933-017-0541-7

Ejemplares similares

Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
por: Wiemer, Marcus, et al.
Publicado: (2017)

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
por: Menown, Ian B. A., et al.
Publicado: (2021)

Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients
por: Wiemer, Marcus, et al.
Publicado: (2015)

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
por: Chisari, Alberto, et al.
Publicado: (2016)

First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry
por: Menown, Ian B.A., et al.
Publicado: (2020)

One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries
por: Vlieger, Selina, et al.
Publicado: (2020)

Intravascular Imaging Guidance Reduce 1-Year MACE in Patients Undergoing Rotablator Atherectomy-Assisted Drug-Eluting Stent Implantation
por: Wongpraparut, Nattawut, et al.
Publicado: (2021)

Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Lee, Cheng-Hung, et al.
Publicado: (2017)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Best Practice in Intravascular Lithotripsy
por: Honton, Benjamin, et al.
Publicado: (2022)

Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease
por: Chaudhary, Rajesh, et al.
Publicado: (2012)

Drug-Eluting Biodegradable Implants for the Sustained Release of Bisphosphonates
por: Dharmayanti, Cintya, et al.
Publicado: (2020)

Additive Manufacturing of Drug-Eluting Multilayer Biodegradable Films
por: Proshin, Pavel I., et al.
Publicado: (2022)

Biodegradable andrographolide-eluting nanofibrous membranes for the treatment of cervical cancer
por: Chen, Yi-Pin, et al.
Publicado: (2019)

Laser Microperforation Assisted Drug-Elution from Biodegradable Films
por: Abdurashitov, Arkady S., et al.
Publicado: (2022)

Clinical outcome of biodegradable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with diabetes
por: Kakizaki, Ryota, et al.
Publicado: (2020)

Long-term outcome of renal nerve denervation (RDN) for resistant hypertension
por: Panchavinnin, Pariya, et al.
Publicado: (2022)

Development of biodegradable zein-based bilayer coatings for drug-eluting stents
por: Lenzuni, Martina, et al.
Publicado: (2021)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
por: Yin, Juntao, et al.
Publicado: (2023)

First successful prevention of cardiopulmonary resuscitation during high-risk percutaneous coronary intervention by use of a pulsatile left ventricular assist device: baptism of fire of the iVAC2L device: a case report
por: Samol, Alexander, et al.
Publicado: (2018)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial
por: Abizaid, Alexandre, et al.
Publicado: (2023)

Cutting balloon to treat post-stenting intramural hematoma during ST elevation myocardial infarction
por: Servoz, Clément, et al.
Publicado: (2021)

Myxoedematous tamponade as initial presentation of Hashimoto’s thyroiditis
por: Casez, Benjamin, et al.
Publicado: (2020)

Transcoronary Rapid Pacing Solving a Complex Retrograde Chronic Total Occlusion Procedure
por: Rougé, Alain, et al.
Publicado: (2019)

Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Drug-Eluting Stents: A Meta-Analysis
por: Ye, Yicong, et al.
Publicado: (2013)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture
por: Ho, Dong-Ru, et al.
Publicado: (2021)

Real-World Clinical Outcomes of Indigenous Biodegradable Polymer Drug-Eluting Stents
por: Kumar, Basant, et al.
Publicado: (2021)

Performance evaluation of biodegradable polymer sirolimus and ascorbic acid eluting stent systems
por: Jo, Won-Il, et al.
Publicado: (2022)

Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus‐Eluting Stent: Real‐World Outcomes From the Multicenter Prospective e‐Ultimaster Registry
por: Codner, Pablo, et al.
Publicado: (2019)

Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
por: Lv, Jianfeng, et al.
Publicado: (2015)

Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study
por: Tappa, Karthik, et al.
Publicado: (2017)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

WATCH-BPM—Comparison of a WATCH-Type Blood Pressure Monitor with a Conventional Ambulatory Blood Pressure Monitor and Auscultatory Sphygmomanometry
por: Vaseekaran, Mathini, et al.
Publicado: (2023)

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents
por: Hemetsberger, Rayyan, et al.
Publicado: (2021)

Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting Stents
por: Iglesias, Juan F., et al.
Publicado: (2019)

Clinical Outcomes of Rotational Atherectomy in Heavily Calcified Lesions: Evidence From the Largest Cardiac Center in Thailand
por: Towashiraporn, Korakoth, et al.
Publicado: (2022)

The Bioengineered Combo Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent in Patients with Chronic Total Occlusion Evaluated by Clinical Outcome and Optical Coherence Tomography Imaging Analysis
por: Blessing, Recha, et al.
Publicado: (2020)

A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study
por: Teeuwen, Koen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bfa2aqvck5oqvms8n5uj64dn34